ARCHIVES

Cancer Center Directors to Develop Blueprint for Progress That’s “Honest,” M.D. Anderson’s John Mendelsohn Says.

This article is from The Cancer Letter archive.

Vol. 32 No. 42 | November 22, 2006

Download PDF Visit The Full Archive

Related Articles

NCI CTEP-Approved Trials For the Month of December

December 26, 2014

Studies Test New Agents Offering Relief From Treatment-Related Side Effects

July 30, 2004

FDA Advisors OK Levamisole, Conditional New Tamoxifen Use

February 9, 1990

The NCI director and acting FDA commissioner called for faster approval of cancer drugs in speech to FDA staff.

October 21, 2005

Study: HPV Testing Can Predict Precancers For Nearly Two Decades Following Exam

August 31, 2012

Where’s The Money for Local Programs? Everyone Wants To Know

February 28, 1975